Furney Natalie Anne Marie's Form 4 filing
Takeda Pharmaceutical Co Ltd (TAK) · filed Aug 12, 2026
- Accession no.
- 0001493152-26-037480
- Filed
- Aug 12, 2026, 9:23 PM ET
- Trade date
- Aug 10, 2026
- Filing delay
- 2 days
- Rule 10b5-1 plan
- Not checked
This filing lists 1 non-derivative transaction and 0 derivative transactions. Open-market sales total $527.8K. It was filed 2 days after the trade.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Furney Natalie Anne MarieCIK 0002111535 | Officer (Global General Counsel) |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Aug 10, 2026 | American Depositary Shares | SSaleDisposed | −30,868 | $17.10 | −$527,842.8 | 204,298 | Direct |
Footnotes
Livermore does not store Form 4 footnotes. For price ranges, how indirect holdings are held and trading plan details, read the original on SEC EDGAR.